PEPTID-OLIGONUKLEOTIDKONJUGATE

European patent · EP3297649 · In force

Register entry

Publication number
EP3297649
Application number
EP16797300
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 19, 2016
Published
Mar 28, 2018
Granted
Oct 11, 2023
Protection ends at the latest
May 18, 2036
Next annual fee due
May 31, 2027
IPC classes
A61K 38/16 (2006.01)
C07K 16/00 (2006.01)
Priority
US 201562163960 P 19.05.2015
US 201662337536 P 17.05.2016
PCT application
PCT/US2016/033276 19.05.2016
PCT publication
WO2016/187425 24.11.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  3. Aug 21, 2024

    Change

    Published in Swissreg on 21.08.2024

  4. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  5. Oct 11, 2023

    Granted

    Published in Swissreg on 11.10.2023

Parties

Holder

Sarepta Therapeutics, Inc.

215 First Street, Cambridge, MA 02142, US

Inventor

HANSON, Gunnar J.

Cambridge, Massachusetts 02142, US

ZHOU, Ming

Cambridge, Massachusetts 02142, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.